Pancreapar (Energique, Inc.)
Welcome to the PulseAid listing for the Pancreapar drug offered from Energique, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Energique, Inc. |
NON-PROPRIETARY NAME: | Syzygium Jambolanum, Glandula Suprarenalis Suis, Hydrastis Canadensis, Hypophysis Suis, Pancreas Suis, Phaseolus, Aceticum Acidum, Lacticum Acidum, Phosphoricum Acidum, Phosphorus, Uranium Nitricum |
SUBSTANCE NAME: | SYZYGIUM CUMINI SEED; SUS SCROFA ADRENAL GLAND; GOLDENSEAL; SUS SCROFA PITUITARY GLAND; SUS SCROFA PANCREAS; KIDNEY BEAN; ACETIC ACID; LACTIC ACID; PHOSPHORIC ACID; PHOSPHORUS; URANYL NITRATE HEXAHYDR |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | LIQUID |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2017-08-04 |
END MARKETING DATE: | 0000-00-00 |
Pancreapar HUMAN OTC DRUG Details:
Item Description | Pancreapar from Energique, Inc. |
LABELER NAME: | Energique, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3; 6; 6; 6; 6; 9; 12; 12; 12; 12; 12([hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL) |
START MARKETING DATE: | 2017-08-04 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 44911-0420_7871b6de-a6fb-4345-9854-f65ea27062d3 |
PRODUCT NDC: | 44911-0420 |
APPLICATION NUMBER: | |
Other SYZYGIUM CUMINI SEED; SUS SCROFA ADRENAL GLAND; GOLDENSEAL; SUS SCROFA PITUITARY GLAND; SUS SCROFA PANCREAS; KIDNEY BEAN; ACETIC ACID; LACTIC ACID; PHOSPHORIC ACID; PHOSPHORUS; URANYL NITRATE HEXAHYDR Pharmaceutical Manufacturers / Labelers: